This year, 4,253 riders took part in The Enbridge Ride to Conquer Cancer. More than $155 million dollars has been raised since the Ride began nine years ago. (Photo: TPMCF)​

The Enbridge Ride to Conquer Cancer announced 4,253 riders raised $17.3 million for The Princess Margaret Cancer Foundation as the ninth annual Ride commenced in Ontario on Saturday.

Funds raised through Canada's largest cycling fundraiser support Personalized Cancer Medicine, the new gold standard in cancer care, at The Princess Margaret, across Ontario, and around the world.

"The Ride is about camaraderie, teamwork and passion and we are extremely grateful to the riders, sponsors, donors, crew members and volunteers, for their efforts in making our ninth annual Ride a tremendous success," said Paul Alofs, President and CEO of The Princess Margaret Cancer Foundation.

"Two out of five Canadians are expected to develop cancer in their lifetime. Funds raised through the Enbridge Ride to Conquer Cancer are vital for our researchers to revolutionize Personalized Cancer Medicine and enable our world-leading doctors and scientists to detect cancers earlier, diagnose and target cancers more precisely and ultimately provide better support and care to patients and their families. The Princess Margaret remains one of the top five cancer centres in the world, and it is our continued mission to conquer cancer in our lifetime," Alofs added.

In nine years, the Enbridge Ride to Conquer Cancer raised more than $155 million for The Princess Margaret Cancer Foundation and more than $321 million for cancer research, treatment, education and care programs across the country.

The annual event draws thousands of participants from around the world and brings together communities of cancer survivors, cyclists and supporters who train and fundraise year-round to participate in the two-day, 200 plus kilometre cycling journey between Toronto and Niagara Falls.

For more information on the Ride, click here.​

To understand the special significance of the Ride to one participant, click here.​

Back to Top